Oslo, 2 June 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical"or the "Company"), will release its first quarter results for 2022 on Friday, 3 June 2022. The presentation will be available on Newsweb and the Company’s website at 07:00 CET. Following the release, CEO, Rune Nystad and CFO, Per Arne Nygård will host a…
Oslo, 28 April 2022 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that it has delivered an additional 58 Biim ultrasound probes to Fresenius Kidney Care in the US, completing the delivery of a total of 260 ultrasound probes in the first phase of the delivery to Fresenius Kidney Care as planned.…
Oslo, April 1, 2022 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that the Sippi® Disposable Unit has received Medical Device Regulation Certification, ensuring continued market access for the unit in Europe after 2024. Rune Nystad, CEO of Observe Medical, commented: "The MDR Certification confirms that the Sippi® Disposable Unit is compliant with…
Oslo, March 28, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), will be announcing its fourth quarter 2021 results on Tuesday 29 March 2022. Members of the Management team will host a presentation at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. The live webcast will…
Oslo, October 22, 2021 – Observe Medical ASA (OSE: OBSRV) continues its rollout of Sippi®, and reports clinical implementation at several sites in Europe – including use outside intensive care units, and clinical evaluations driving the health economic value of Sippi® “We are excited to see Sippi® implementation gaining momentum as society and hospitals now…
Oslo, September 27th, 2021 – Observe Medical ASA (OSE: OBSRV) continues its rollout of Sippi®, and today announces that a major regional hospital in Italy has decided to implement Sippi® in the intensive care unit (ICU), with wireless connection to the hospital’s patient data management system. “The decision by a major Italian hospital to implement…
Oslo June 30, 2021 – Observe Medical ASA (OSE: OBSRV), today announces that it has entered into a distribution agreement and partnership with Skamex (Poland) for the launch of Sippi® in the Polish and the Romanian market. “We are pleased to announce that we are taking additional steps in the roll-out of Sippi® through our…
Oslo May 07, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Nya Karolinska Sjukhuset, Sweden, prepares new studies to broaden the clinical scope of use for Sippi® automated, digital urine measurement system, building further on the results from the recent dissertation by Dr Martin Slettengren. Following the recent dissertation by Dr. Martin Slettengren, ”Evaluation…
Oslo May 6, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Sippi® automated and digital urine meter recently received new patent approvals in India, China and Brazil, further expanding and strengthening the global patent protection for Sippi® proprietary technology. “We are pleased to announce that Sippi® since end March this year, has received three…
Oslo 8 March 2021 – Observe Medical ASA (OSE: OBSERV), today announces an order to deliver a newly introduced blood & fluid warmer system, including disposable supplies, to two university hospitals and one regional hospital in Nordic market. “This is a breakthrough order for an innovative and newly introduced blood & fluid warmer system and…
Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19 As a result of the recent improvements of the Covid-19 situation at the hospital, the…
Oslo February 12, 2021 – Observe Medical ASA (OSE: OBSERV), announces that a major hospital in Northern Italy has equipped the ICU department with Sippi® systems in clinical use, the result of the close collaboration with Observe Medical distributor in Italy, SIM Italia. As a result of the strengthened partnership in 2020 with the distributor…
Oslo February 4, 2021 – Observe Medical ASA (OSE: OBSERV), announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech. Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe.…
Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation…
Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market. Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe,…
A recently published article demonstrates that the patented Sippcoat® technology, an integrated part of Sippi® system, from Observe Medical, significantly reduces microbial biofilm formation in medical devices, suggesting a new strategy for reducing hospital-acquired infections. The article “Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation” was recently published in…
Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement…
Oslo, 19 March 2020 – Observe Medical ASA (OSE: OBSERV) today provides a business update in light of COVID-19. The company reports continued high activity level in operations, and several initiatives in the launch and roll-out of Sippi®. “The evolving COVID-19 situation has serious impact on all aspects of the global society, specifically the healthcare…
Observe Medical ASA invites you to a presentation of the fourth quarter and full year 2019 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, February 25th.